Teresa Macarulla Mercade

18PUBLICATIONS
259CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jun 25, 2026
Biomarker analysis from patients with metastatic PDAC treated with TGFβ antibody, NIS793, plus abraxane+gemcitabine vs. abraxane+gemcitabine alone in a phase II, open label, randomized study.

|Jun 09, 2026
A phase Ib/2a study of fostrox in combination with lenvatinib as second line therapy in patients with advanced hepatocellular carcinoma.

|Jun 01, 2026
Next generation sequencing of circulating tumor DNA for precision medicine in patients with advanced biliary tract cancers.

|Mar 31, 2026
Existing challenges in the management of cholangiocarcinoma in Spain.

Andrés Jesús Muñoz Martín, Angela Lamarca, Jesus M Banales

|Dec 29, 2025
MAPK Pathway Mutations Emerge in Mutant IDH1 Inhibitor-Resistant Cholangiocarcinoma and Attenuate the IFN Response.

Jinkai Wan, Hatice Duygu Saatcioglu, Haley Ellis

|Nov 04, 2025
TRYBECA-1: A Randomized Phase III Study of Eryaspase Combined With Chemotherapy Versus Chemotherapy as Second-Line Treatment in Patients With Advanced Pancreatic Adenocarcinoma.

Pascal Hammel, Jean-Philippe Metges, Teresa Macarulla Mercade

Pageof 3

Frequent Collaborators

4 joint publications

Do-Youn Oh

3 joint publications

Carles Fabregat-Franco

3 joint publications

Gerald W Prager

3 joint publications

Joon Oh Park